Cargando…
Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells
BACKGROUND: Metformin is an oral anti-diabetic agent that has been widely prescribed for treatment of type II diabetes. Anti-cancer properties of metformin have been revealed for numerous human malignancies including cholangiocarcinoma (CCA) with anti-proliferative effects in vitro. However, effects...
Autores principales: | Son, Trinh Xuan, Huyen, Nguyen Thi Bich, Saimuang, Kween, Prachayasittikul, Virapong, On, Waraporn Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454745/ https://www.ncbi.nlm.nih.gov/pubmed/28345832 http://dx.doi.org/10.22034/APJCP.2017.18.2.473 |
Ejemplares similares
-
Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells
por: Chan-on, Waraporn, et al.
Publicado: (2015) -
Curcumin enhances chemotherapeutic effects and suppresses ANGPTL4 in anoikis-resistant cholangiocarcinoma cells
por: San, Tin Tin, et al.
Publicado: (2020) -
Increased sensitivity of enterotoxigenic Escherichia coli detection in stool samples using oligonucleotide immobilized-magnetic nanoparticles
por: Jangpatarapongsa, Kulachart, et al.
Publicado: (2021) -
P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016) -
Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose
por: Suwanjang, Wilasinee, et al.
Publicado: (2016)